Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CHNA

Loncar China Biopharma ETF (CHNA) Price, Holdings, & News

Loncar China Biopharma ETF logo

About Loncar China Biopharma ETF (NASDAQ:CHNA)

Advanced Chart

Key Stats

Today's Range
$13.53
$13.53
50-Day Range
$13.53
$14.77
52-Week Range
$13.35
$22.89
Volume
9 shs
Average Volume
538 shs
Market Capitalization
$10.56 million
Assets Under Management
$3.74 million
Dividend Yield
0.44%
Net Expense Ratio
0.79%
Aggregate Rating
N/A

ETF Overview

The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.

Loncar China Biopharma ETF Expenses

TypeCHNAHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.79%0.57%0.57%0.54%0.54%
Other Expenses0.00%0.30%0.48%0.42%0.51%
Total Expense0.79%0.70%0.72%0.69%0.71%
Fee Waiver0.00%-0.45%-0.49%-0.29%-0.54%
Net Expense0.79%0.60%0.63%0.62%0.60%
Receive CHNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter.

CHNA ETF News Headlines

Roundhill China Dragons ETF
Elon’s final win for Social Security?
Elon's Successor? Elon Musk and President Trump's new feud is all over the news... but before he left Washington, Musk left a "parting gift," which could help you double your money multiple times this year. It has nothing to do with EVs, the spending bill, or anything else being reported right now.. but it could send trillions into the economy. And it could create more wealth than all of his previous ventures... put together.
Liaoning Chengda Biotechnology Co. Ltd. A
See More Headlines

CHNA ETF - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Loncar China Biopharma ETF investors own include Alibaba Group (BABA), Baidu (BIDU), Nokia Oyj (NOK), AT&T (T), Tencent (TCEHY), Tesla (TSLA) and Advanced Micro Devices (AMD).

Fund Details

Issuer
Exchange Traded Concepts
Fund Name
Loncar China Biopharma ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:CHNA
Inception Date
8/14/2018
Fund Manager
Denise M. Krisko, Habib Moudachirou
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Loncar China BioPharma Index
Category
Sector
Focus
Health Care
Development Level
Emerging Markets
Region
Asia-Pacific
Number of Holdings
89

Fund Statistics

Assets Under Management
$3.74 million
Average Daily Volume
$1.20 thousand
Discount/Premium
-0.06%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Exchange Traded Concepts, LLC
Custodian
U.S. Bank, N.A.
Distributor
Quasar Distributors, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
GTS

Miscellaneous

Beta
0.95
Creation Unit
50,000
Creation Fee
$750.00
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Top 2 CHNA Holdings

  • US DOLLARS
    Holding Weight: 99.94%
  • DEPOSITS WITH BROKER FOR SHORT POSITIONS
    Holding Weight: 0.06%

This page (NASDAQ:CHNA) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners